Envisioning the future of dyslipidaemia management - discussion

5 More presentations in this session

Setting the stage: the unmet need in high-risk patients

Professor K. Ray (London, GB)

From stepwise to swift: the rationale for early initiation of combination therapy

Professor K. Parhofer (Munich, DE)

A new chapter for lipid control: the science

Professor U. Laufs (Leipzig, DE)

A new chapter for lipid control: the evidence

Professor E. Michos (Baltimore, US)

Closing remarks and EBAC evaluation

Professor K. Ray (London, GB)